Annual EBITDA
-$32.28M$461.40M+93.46%
Summary
- Current Value
- As of today, ALVO annual EBITDA is -$32.28M, up +93.46% on
- Historical Performance
- ALVO annual EBITDA is down -79.00% over the past 3 years, and up +67.41% over the past 5 years
- All-Time High Comparison
- ALVO annual EBITDA is currently -79.00% below its historical high of -$18.03M set on
- 3-Year Low Comparison
- ALVO annual EBITDA is +93.46% above its 3-year low of -$493.67M reached on
- Sector Comparison
- ALVO annual EBITDA is higher than 38.30% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$32.28M | +93.5% | -79.0% | +67.4% | +67.4% | |
| Quarterly EBITDA | $11.48M | -45.4% | +120.1% | +10000.0% | +10000.0% | |
| TTM EBITDA | $53.76M | +405.8% | +120.7% | +10000.0% | +10000.0% | |
| Price | $5.24 | -60.1% | -56.1% | – | – | |
| PE Ratio | 22.75 | – | – | – | – | |
| Annual Revenue | $489.68M | +435.6% | +100.0% | +1434.2% | +1434.2% | |
| Annual EPS | -$0.87 | +64.3% | -777.1% | +54.4% | +54.4% | |
| Annual EBIT | -$63.58M | +87.7% | -75.5% | +44.0% | +44.0% | |
| Annual Net Income | -$231.86M | +58.0% | -5906.5% | -10.5% | -10.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$32.28M | at high | |
| 5Y | -$18.03M | -79.0% | |
| All | -$18.03M | -79.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$493.67M | +93.5% | |
| 5Y | -$493.67M | +93.5% | |
| All | -$493.67M | +93.5% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$32.28M | +93.5% | |
| -$493.67M | -8.8% | |
| -$453.76M | -2,416.6% |
| Year | Value | Change |
|---|---|---|
| -$18.03M | +89.9% | |
| -$177.89M | -79.6% | |
| -$99.02M | - |
FAQ
What is the current annual EBITDA of ALVO?
As of today, ALVO annual EBITDA is -$32.28M
What is 1-year change in ALVO annual EBITDA?
ALVO annual EBITDA is up +93.46% year-over-year
What is 3-year change in ALVO annual EBITDA?
ALVO annual EBITDA is down -79.00% over the past 3 years
How far is ALVO annual EBITDA from its all-time high?
ALVO annual EBITDA is currently -79.00% below its historical high of -$18.03M set on December 31, 2021
How does ALVO annual EBITDA rank versus sector peers?
ALVO annual EBITDA is higher than 38.30% of companies in Healthcare sector
When is ALVO next annual earnings release?
The next annual earnings release for ALVO is on
Quarterly EBITDA
$11.48M$15.38M-57.26%
Summary
- Current Value
- As of today, ALVO quarterly EBITDA is $11.48M, down -57.26% on
- Historical Performance
- ALVO quarterly EBITDA is down -45.40% year-over-year, and up +120.13% over the past 3 years
- All-Time High Comparison
- ALVO quarterly EBITDA is currently -88.45% below its historical high of $99.41M set on
- 3-Year Low Comparison
- ALVO quarterly EBITDA is +112.55% above its 3-year low of -$91.45M reached on
- Sector Comparison
- ALVO quarterly EBITDA is higher than 78.79% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $11.48M | -57.3% | -45.4% | +120.1% | +10000.0% | |
| Annual EBITDA | -$32.28M | – | +93.5% | -79.0% | +67.4% | |
| TTM EBITDA | $53.76M | -15.1% | +405.8% | +120.7% | +10000.0% | |
| Price | $5.24 | -35.7% | -60.1% | -56.1% | – | |
| PE Ratio | 22.75 | -35.7% | – | – | – | |
| Quarterly Revenue | $113.74M | -34.3% | +10.6% | +497.0% | +100.0% | |
| Quarterly EPS | -$0.02 | -116.4% | +54.0% | +49.7% | +66.8% | |
| Quarterly EBIT | $0.00 | -100.0% | -100.0% | +100.0% | +100.0% | |
| Quarterly Net Income | -$5.25M | -116.4% | +53.9% | +38.9% | -221.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $26.85M | -57.3% | |
| 3Y | $99.41M | -88.5% | |
| 5Y | $99.41M | -88.5% | |
| All | $99.41M | -88.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$4.06M | +382.8% | |
| 3Y | -$91.45M | +112.5% | |
| 5Y | -$132.99M | +108.6% | |
| All | -$132.99M | +108.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ALVO?
As of today, ALVO quarterly EBITDA is $11.48M
What is ALVO quarterly EBITDA most recent change?
ALVO quarterly EBITDA was down -57.26% on September 30, 2025
What is 1-year change in ALVO quarterly EBITDA?
ALVO quarterly EBITDA is down -45.40% year-over-year
How far is ALVO quarterly EBITDA from its all-time high?
ALVO quarterly EBITDA is currently -88.45% below its historical high of $99.41M set on June 30, 2024
How does ALVO quarterly EBITDA rank versus sector peers?
ALVO quarterly EBITDA is higher than 78.79% of companies in Healthcare sector
When is ALVO next earnings release?
The next earnings release for ALVO is on
TTM EBITDA
$53.76M$9.54M-15.08%
Summary
- Current Value
- As of today, ALVO TTM EBITDA is $53.76M, down -15.08% on
- Historical Performance
- ALVO TTM EBITDA is up +405.77% year-over-year, and up +120.66% over the past 3 years
- All-Time High Comparison
- ALVO TTM EBITDA is currently -60.43% below its historical high of $135.86M set on
- 3-Year Low Comparison
- ALVO TTM EBITDA is +114.99% above its 3-year low of -$358.71M reached on
- Sector Comparison
- ALVO TTM EBITDA is higher than 81.41% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $53.76M | -15.1% | +405.8% | +120.7% | +10000.0% | |
| Annual EBITDA | -$32.28M | – | +93.5% | -79.0% | +67.4% | |
| Quarterly EBITDA | $11.48M | -57.3% | -45.4% | +120.1% | +10000.0% | |
| Price | $5.24 | -35.7% | -60.1% | -56.1% | – | |
| PE Ratio | 22.75 | -35.7% | – | – | – | |
| TTM Revenue | $548.10M | +2.0% | +49.2% | +826.3% | +100.0% | |
| TTM EPS | $0.23 | +9.7% | +113.9% | +107.5% | +539.5% | |
| TTM EBIT | $16.97M | -42.6% | +135.8% | +107.5% | +10000.0% | |
| TTM Net Income | $69.50M | +9.7% | +115.7% | +135.3% | +4348.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $135.86M | -60.4% | |
| 3Y | $135.86M | -60.4% | |
| 5Y | $135.86M | -60.4% | |
| All | $135.86M | -60.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $53.76M | at low | |
| 3Y | -$358.71M | +115.0% | |
| 5Y | -$358.71M | +115.0% | |
| All | -$358.71M | +115.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ALVO?
As of today, ALVO TTM EBITDA is $53.76M
What is ALVO TTM EBITDA most recent change?
ALVO TTM EBITDA was down -15.08% on September 30, 2025
What is 1-year change in ALVO TTM EBITDA?
ALVO TTM EBITDA is up +405.77% year-over-year
How far is ALVO TTM EBITDA from its all-time high?
ALVO TTM EBITDA is currently -60.43% below its historical high of $135.86M set on March 31, 2025
How does ALVO TTM EBITDA rank versus sector peers?
ALVO TTM EBITDA is higher than 81.41% of companies in Healthcare sector
When is ALVO next earnings release?
The next earnings release for ALVO is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- ALVO Official Website www.alvotech.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1898416/000162828025015052/0001628280-25-015052-index.htm
- ALVO Profile on Yahoo Finance finance.yahoo.com/quote/ALVO
- ALVO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alvo